Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript
11:38am, Tuesday, 18'th Nov 2025
Revvity, Inc. ( RVTY ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:00 AM EST Company Participants Maxwell Krakowiak - Senior VP & CFO Prahlad Singh - CEO, President & Director Conf
Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript
10:11am, Monday, 10'th Nov 2025
Revvity, Inc. ( RVTY ) UBS Global Healthcare Conference 2025 November 10, 2025 8:00 AM EST Company Participants Maxwell Krakowiak - Senior VP & CFO Conference Call Participants Daniel Leonard - UBS In
Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy
08:00am, Monday, 10'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
07:45am, Monday, 10'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that sup
Revvity Inc. $RVTY Shares Sold by Asset Management One Co. Ltd.
03:38am, Wednesday, 29'th Oct 2025
Asset Management One Co. Ltd. lowered its position in shares of Revvity Inc. (NYSE: RVTY) by 1.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission
Revvity Analysts Increase Their Forecasts After Q3 Earnings
09:32am, Tuesday, 28'th Oct 2025
Revvity, Inc. (NYSE:RVTY) announced mixed third-quarter 2025 financial results on Monday.
Revvity to Present at Upcoming Investor Conferences
08:00am, Tuesday, 28'th Oct 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00
Revvity: Software Momentum And Screening Offset China Weakness
12:56pm, Monday, 27'th Oct 2025
Revvity, Inc. operates across two main segments in Life Sciences tools and Diagnostics. Its cloud informatics Signals continue experiencing double-digit growth, while diagnostics in China suffer from
Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript
12:47pm, Monday, 27'th Oct 2025
Revvity, Inc. (NYSE:RVTY ) Q3 2025 Earnings Call October 27, 2025 8:00 AM EDT Company Participants Stephen Willoughby - Senior VP of Investor Relations & Head of ESG Prahlad Singh - CEO, President & D
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
11:06am, Monday, 27'th Oct 2025
Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.
Revvity (RVTY) Reports Q3 Earnings: What Key Metrics Have to Say
10:31am, Monday, 27'th Oct 2025
Although the revenue and EPS for Revvity (RVTY) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Str
Revvity (RVTY) Surpasses Q3 Earnings Estimates
08:11am, Monday, 27'th Oct 2025
Revvity (RVTY) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.28 per share a year ago.
Revvity lifts annual profit forecast on renewed demand in diagnostics unit
07:06am, Monday, 27'th Oct 2025
Medical equipment maker Revvity on Monday raised its annual profit forecast and beat third-quarter estimates on improving demand for its testing kits in the diagnostics unit.
Revvity Announces Financial Results for the Third Quarter of 2025
06:00am, Monday, 27'th Oct 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended September 28, 2025. The Company reported GAAP earnings per share of $0.40, as
Revvity Board Declares Quarterly Dividend
04:05pm, Thursday, 23'rd Oct 2025
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on Febru
